huge volume entering anp, page-24

We should be up for the next volume push now should be our previous run up be any indication for the timing of the accumulation.


From Monday last week's 24th Annual ROTH Conference we got a good overlook over the Antisense pipeline which a colleague of mine had the pleasure to participate in and listen to Stanley in person which he told me was inspiring to many in the audience.
I would recommend investors here to have a listen into the broadcast to get an overview of the exciting drug development we are part of.

There should be a wave of investment hitting ANP once the US investors include our drugs pipelines into their radar.


Severe rare deseases gets a special mention with ATL1103.

Growth hormone receptor drug SIGNIFICANTLY improved all the measures of growth hormone activity in acromegaly.


I see the latest trading attention for ANP as a reflection, amongst other factors, of recent mentions of ATL1003 in numerous presentations in the US and larger investors ready to moving in early to take a bite.
The move just started should take us eventually well past the recently established high of 3.9 cents.







24th Annual ROTH Conference